Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

CNBXCNBX Pharmaceuticals Inc.

OTC · CIK 0001343009
Filer category<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end0831
XBRL facts292

Identity from submissions API

NameCNBX Pharmaceuticals Inc.
CIK0001343009
TickersCNBX
ExchangesOTC
Entity typeoperating
Category<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN203373669
LEI—
Fiscal year end0831
State of incorporationNV NV
Phone877-424-2429
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)1

Former names

  • Cannabics Pharmaceuticals Inc. (2014-06-20T04:00:00.000Z → 2022-03-16T04:00:00.000Z)
  • American Mining Corp (2011-05-13T04:00:00.000Z → 2014-05-01T04:00:00.000Z)
  • Thrust Energy Corp. (2006-01-09T05:00:00.000Z → 2011-05-10T04:00:00.000Z)
Business address
#3 BETHESDA METRO CENTER
SUITE 700
BETHESDA
MD
20814
MD
Mailing address
#3 BETHESDA METRO CENTER
SUITE 700
BETHESDA
MD
20814
MD

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

302 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-12 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-126207 005-83146 261546760 34 16543
2026-10-01 8-K CURRENT REPORT 4.01,9.01 0001683168-26-007522 000-52403 261430525 34 307047 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001753926-26-001524 005-83146 261283354 34 16572
2026-06-24 10-Q FORM 10-Q FOR MAY 2026 0001683168-26-005078 000-52403 261113120 34 2296268 1 1
2026-05-08 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001753926-26-000803 005-83146 26959630 34 17293
2026-04-14 10-Q FORM 10-Q 0001683168-26-002899 000-52403 26859817 34 2424491 1 1
2026-03-17 8-K FORM 8-K 1.01,9.01 0001683168-26-001883 000-52403 26759200 34 3431840 1 1
2026-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001753926-26-000272 005-83146 26602921 34 15593
2026-01-14 10-Q QUARTERLY REPORT 0001683168-26-000285 000-52403 26531569 34 1999298 1 1
2025-12-01 10-K FORM 10-K FOR AUG 2025 0001683168-25-008736 000-52403 251537218 34 3670075 1 1
2025-11-10 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001753926-25-001728 005-83146 251467175 34 15764
2025-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001753926-25-001322 005-83146 251211472 34 15587
2025-07-14 10-Q FORM 10-Q 0001683168-25-005075 000-52403 251120279 34 1962103 1 1
2025-05-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001753926-25-000800 005-83146 25942288 34 15621
2025-04-14 10-Q 10-Q 0001683168-25-002511 000-52403 25834335 34 2072530 1 1
2025-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001753926-25-000250 005-83146 25620210 34 15443
2025-01-30 8-K FORM 8-K 1.01,9.01 0001683168-25-000583 000-52403 25570655 34 301608 1 1
2025-01-13 10-Q FORM 10-Q FOR NOV 2024 0001683168-25-000267 000-52403 25524956 34 1824345 1 1
2024-11-29 10-K FORM 10-K FOR AUGUST 2024 0001683168-24-008433 000-52403 241513096 34 3706450 1 1
2024-11-14 SC 13G/A SC 13G/A 0001753926-24-001918 005-83146 241462299 34 78232
2024-07-15 10-Q FORM 10-Q 0001683168-24-004831 000-52403 241116159 34 2123621 1 1
2024-06-17 UPLOAD filename1.pdf 0000000000-24-006950 000-52403 40065
2024-06-06 CORRESP filename1.htm 0001683168-24-004012 9103
2024-05-30 UPLOAD filename1.pdf 0000000000-24-006211 000-52403 45709
2024-05-21 CORRESP filename1.htm 0001683168-24-003766 16986
2024-04-22 UPLOAD filename1.pdf 0000000000-24-004407 000-52403 47810
2024-04-16 10-Q FORM 10-Q FOR FEBRUARY 2024 0001683168-24-002440 000-52403 24846744 34 2583406 1 1
2024-04-15 NT 10-Q EXTENSION 0001683168-24-002385 000-52403 24843423 34 20267
2024-04-10 CORRESP filename1.htm 0001683168-24-002261 20145
2024-03-22 8-K FORM 8-K 4.01,9.01 0001683168-24-001610 000-52403 24773247 34 212448 1 1
2024-02-13 SC 13G/A SC 13G/A 0001753926-24-000285 005-83146 24626447 34 64616
2024-01-29 UPLOAD filename1.pdf 0000000000-24-001084 000-52403 47978
2024-01-12 10-Q QUARTERLY REPORT 0001683168-24-000255 000-52403 24530912 34 2169266 1 1
2023-11-30 10-K FORM 10-K FOR AUG 2023 0001683168-23-008557 000-52403 231453820 34 4627012 1 1
2023-07-14 10-Q QUARTERLY REPORT 0001683168-23-004890 000-52403 231088266 34 1756968 1 1
2023-04-14 10-Q QUARTERLY REPORT 0001683168-23-002379 000-52403 23820031 34 2467631 1 1
2023-03-06 SC 13G SC 13G 0001753926-23-000250 005-83146 23709770 34 90057
2023-02-08 8-K CURRENT REPORT 5.02 0001683168-23-000628 000-52403 23597110 34 189430 1 1
2023-01-13 10-Q FORM 10-Q 0001683168-23-000174 000-52403 23527348 34 2069335 1 1
2022-12-29 8-K FORM 8-K 5.02 0001683168-22-008672 000-52403 221498497 34 189280 1 1
2022-12-27 RW REGISTRATION WITHDRAWL 0001683168-22-008633 333-262856 221486811 NE 6518
2022-11-30 10-K FORM 10-K 0001683168-22-008095 000-52403 221434601 34 4298214 1 1
2022-07-25 8-K FORM 8-K 5.02 0001683168-22-005100 000-52403 221102243 34 193447 1 1
2022-07-14 10-Q FORM 10-Q 0001683168-22-004948 000-52403 221082231 34 1659844 1 1
2022-05-13 8-K FORM 8-K 5.03,9.01 0001683168-22-003584 000-52403 22923299 34 436208 1 1
2022-04-12 10-Q FORM 10-Q 0001683168-22-002526 000-52403 22821315 34 1518816 1 1
2022-03-28 8-K FORM 8-K 5.03,8.01,9.01 0001683168-22-001999 000-52403 22776196 34 813837 1 1
2022-03-16 8-K FORM 8-K 1.01,2.03,9.01 0001683168-22-001701 000-52403 22742566 34 277907 1 1
2022-02-18 S-1 FORM S-1 0001683168-22-001154 333-262856 22652580 33 3802504 1 1
2022-02-17 8-K FORM 8-K 1.01,9.01 0001683168-22-001084 000-52403 22645749 34 229190 1 1
2022-02-15 DEF 14C DEFINITIVE PROXY STATEMENT 0001683168-22-001036 000-52403 22639589 34 532528
2022-02-04 PRE 14C PRELIMINARY INFORMATION STATEMENT 0001683168-22-000684 000-52403 22591089 34 531730
2022-01-13 10-Q FORM 10-Q 0001683168-22-000244 000-52403 22528525 34 2793091 1 1
2021-11-29 10-K cannabics_10k-083121.htm 0001683168-21-006005 000-52403 211456297 34 2831858 1
2021-11-19 8-K CURRENT REPORT 5.02 0001683168-21-005846 000-52403 211427993 34 15724
2021-09-13 8-K FORM 8-K 5.02,9.01 0001683168-21-004239 000-52403 211248770 34 21279
2021-07-19 8-K FORM 8-K 5.02,9.01 0001683168-21-003010 000-52403 211097846 34 20453
2021-07-14 10-Q FORM 10-Q 0001683168-21-002970 000-52403 211090226 34 1436493 1
2021-07-06 8-K FORM 8-K 5.02,9.01 0001683168-21-002832 000-52403 211073227 34 21117
2021-05-17 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-05-17 16:00:00 9999999995-21-001982 333-255948 21933690 33 1928
2021-05-14 UPLOAD filename1.pdf 0000000000-21-006169 40441
2021-05-14 CORRESP filename1.htm 0001683168-21-001987 9520
2021-05-10 S-1 FORM S-1 0001683168-21-001843 333-255948 21905623 33 3407004 1
2021-04-28 8-K FORM 8-K 1.01,5.04,9.01 0001683168-21-001563 000-52403 21861370 34 1061507
2021-04-14 10-Q QUARTERLY REPORT 0001683168-21-001374 000-52403 21825122 34 1323695 1
2021-03-11 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-03-11 16:00:00 9999999995-21-000904 333-252454 21735286 33 1928
2021-03-10 CORRESP filename1.htm 0001683168-21-000860 8867
2021-03-09 CORRESP filename1.htm 0001683168-21-000838 18735
2021-03-08 UPLOAD filename1.pdf 0000000000-21-002718 43441
2021-02-23 CORRESP filename1.htm 0001683168-21-000677 19369
2021-02-23 S-1/A FORM S-1 AMENDMENT 0001683168-21-000676 333-252454 21665059 33 1875333
2021-02-09 UPLOAD filename1.pdf 0000000000-21-001641 47033
2021-01-27 S-1 REGISTRATION STATEMENT 0001683168-21-000268 333-252454 21557192 33 4165681 1
2021-01-14 10-Q FORM 10-Q 0001683168-21-000156 000-52403 21528762 34 1083231 1
2020-12-21 8-K FORM 8-K 1.01,9.01 0001683168-20-004392 000-52403 201402549 34 1545510
2020-11-16 8-K FORM 8-K 7.01,9.01 0001683168-20-003926 000-52403 201314429 34 49655
2020-11-04 10-K ANNUAL REPORT 0001683168-20-003686 000-52403 201285699 34 2511913 1
2020-09-02 8-K FORM 8-K 5.02,9.01 0001683168-20-002982 000-52403 201156849 34 28112
2020-07-14 10-Q FORM 10-Q 0001683168-20-002257 000-52403 201026748 34 1233526 1
2020-04-17 8-K FORM 8-K 7.01 0001683168-20-001222 000-52403 20797474 34 17134
2020-04-17 8-K FORM 8-K 5.02 0001683168-20-001220 000-52403 20797472 34 37956
2020-04-13 10-Q FORM 10-Q 0001683168-20-001154 000-52403 20788870 34 1213560 1
2020-01-14 10-Q FORM 10-Q 0001683168-20-000137 000-52403 20526080 34 858750 1
2019-11-29 10-K FORM 10-K 0001683168-19-003852 000-52403 191259913 34 2600905 1
2019-11-08 8-K FORM 8-K 5.01,9.01 0001683168-19-003492 000-52403 191201455 34 21730
2019-11-07 8-K FORM 8-K 4.01,9.01 0001683168-19-003491 000-52403 191201287 34 58202
2019-10-11 8-K FORM 8-K 5.02,9.01 0001683168-19-003238 000-52403 191148262 34 25030
2019-10-07 8-K FORM 8-K 5.02,9.01 0001683168-19-003192 000-52403 191140056 34 24205
2019-10-03 8-K FORM 8-K 5.02,9.01 0001683168-19-003153 000-52403 191135056 34 23899
2019-07-23 8-K FORM 8-K 4.01,9.01 0001683168-19-002287 000-52403 19967518 34 28936
2019-07-15 10-Q FORM 10-Q 0001683168-19-002195 000-52403 19955129 34 1054682 1
2019-06-25 8-K FORM 8-K 5.02,9.01 0001683168-19-002002 000-52403 19917648 34 30916
2019-04-15 10-Q FORM 10-Q 0001683168-19-001033 000-52403 19748098 34 826897 1
2019-03-27 SC 13G SCHEDULE 13G 0001683168-19-000791 45879
2019-02-13 8-K FORM 8-K 1.01,3.02,9.01 0001683168-19-000364 000-52403 19593551 34 92850
2019-02-04 3 OWNERSHIP DOCUMENT 0001178913-19-000244 333-208814 19562909 34 4063
2019-01-17 10-Q FORM 10-Q 0001683168-19-000146 000-52403 19530310 34 803484 1
2019-01-14 NT 10-Q NOTICE OF LATE FILING 0001683168-19-000094 000-52403 19525545 34 18518
2018-11-29 10-K ANNUAL REPORT 0001683168-18-003584 000-52403 181208072 34 2250011 1
2018-09-27 8-K FORM 8-K 1.01,3.02,8.01,9.01 0001683168-18-002858 000-52403 181089167 34 524742
2018-09-26 424B5 424B5 0001683168-18-002842 333-216845 181086889 33 319738
2018-09-12 424B2 FORM 424 (B)(2) 0001683168-18-002713 333-216845 181066048 33 18377
2018-08-21 424B2 424B2 PROSPECTUS SUPPLEMENT 0001683168-18-002447 333-216845 181030097 33 14816
2018-08-14 8-K FORM 8-K 1.01,9.01 0001683168-18-002294 000-52403 181015875 34 64030
2018-07-16 10-Q FORM 10-Q 0001683168-18-001952 000-52403 18953579 34 1076614 1
2018-06-01 424B2 PROSPECTUS SUPPLEMENT 0001683168-18-001575 333-216845 18875481 33 284584
2018-05-31 424B2 PROSPECTUS SUPPLEMENT 0001683168-18-001571 333-216845 18872055 33 272657
2018-05-02 8-K cannabics_8k.htm 1.01,9.01 0001683168-18-001146 000-52403 18797816 34 248086
2018-04-05 10-Q FORM 10-Q 0001683168-18-000930 000-52403 18739839 34 1582826 1
2018-02-14 8-K FORM 8-K 5.02,9.01 0001683168-18-000393 000-52403 18605503 34 18658
2018-01-30 8-K FORM 8-K 5.02,9.01 0001683168-18-000256 000-52403 18558693 34 27218
2018-01-16 10-Q FORM 10-Q 0001683168-18-000132 000-52403 18527344 34 1057904 1
2017-12-19 8-K FORM 8-K 1.01,9.01 0001683168-17-003350 000-52403 171263987 34 65971
2017-12-08 10-K FORM 10-K 0001683168-17-003260 000-52403 171246199 34 2298095 1
2017-11-29 NT 10-K EXTENSION 0001683168-17-003167 000-52403 171228186 34 14817
2017-11-13 8-K CURRENT REPORT 4.01,9.01 0001683168-17-002932 000-52403 171195512 34 24844
2017-11-13 8-K CURRENT REPORT 5.02,9.01 0001683168-17-002931 000-52403 171195503 34 19852
2017-07-17 10-Q FORM 10-Q 0001683168-17-001782 000-52403 17967028 34 1027605 1
2017-05-10 8-K FORM 8-K 1.01,9.01 0001683168-17-001144 000-52403 17828463 34 268698
2017-05-10 424B5 PROSPECTUS SUPPLEMENT 0001683168-17-001143 333-216845 17828462 33 287182
2017-04-21 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2017-04-21 13:00:00 9999999995-17-000899 333-216845 17777081 33 1928
2017-04-19 CORRESP filename1.htm 0001683168-17-000976 7747
2017-04-14 10-Q FORM 10-Q 0001683168-17-000931 000-52403 17762251 34 1035953 1
2017-04-07 CORRESP filename1.htm 0001683168-17-000841 10699
2017-04-07 S-3/A AMENDMENT NO. 1 0001683168-17-000840 333-216845 17747939 33 238119
2017-04-06 UPLOAD filename1.pdf 0000000000-17-011770 138963
2017-03-21 S-3 FORM S-3 REGISTRATION STATEMENT 0001683168-17-000616 333-216845 17703635 33 852513
2017-03-15 10-K/A 10-K/A 0001683168-17-000570 000-52403 17690633 34 573357
2017-01-17 10-Q FORM 10-Q 0001683168-17-000085 000-52403 17529816 34 791357 1
2016-12-21 144 FORM 144 0001213900-16-019590 000-52403 162063596 33 46149
2016-12-13 10-K FORM 10-K 0001683168-16-000925 000-52403 162048483 34 1919134 1
2016-12-13 8-K FORM 8-K 5.02,9.01 0001683168-16-000924 000-52403 162048477 34 24385
2016-11-29 NT 10-K EXTENSION 0001683168-16-000802 000-52403 162021574 34 14976
2016-07-13 10-Q FORM 10-Q 0001019687-16-006908 000-52403 161764611 34 947841 1
2016-04-18 10-Q QUARTERLY REPORT 0001019687-16-005913 000-52403 161576528 34 908841 1
2016-04-15 NT 10-Q CANNABICS PHARMACEUTICALS INC. 0001019687-16-005898 000-52403 161572697 34 14676
2016-04-08 10-Q/A FORM 10-Q/A 0001019687-16-005788 000-52403 161560946 34 1708591 1
2016-03-22 8-K FORM 8-K 4.01,9.01 0001019687-16-005547 000-52403 161521739 34 29032
2016-03-15 UPLOAD filename1.pdf 0000000000-16-068400 136114
2016-02-22 CORRESP filename1.htm 0001019687-16-005248 31569
2016-02-22 8-K CURRENT REPORT ON FORM 8-K 1.01,9.01 0001019687-16-005246 000-52403 161444645 34 30015
2016-01-29 8-K CURRENT REPORT ON FORM 8-K 1.01,5.02,9.01 0001019687-16-004971 000-52403 161373546 34 81025
2016-01-22 10-Q QUARTERLY REPORT 0001019687-16-004908 000-52403 161354830 34 923095 1
2016-01-14 NT 10-Q EXTENSION 0001019687-16-004823 000-52403 161342604 34 14627
2016-01-07 10-K ANNUAL REPORT 0001019687-16-004727 000-52403 161328002 34 1743461 1
2015-12-23 CORRESP filename1.htm 0001019687-15-004628 55076
2015-12-01 UPLOAD filename1.pdf 0000000000-15-055851 42807
2015-11-30 NT 10-K EXTENSION 0001019687-15-004358 000-52403 151259283 34 13881
2015-11-17 10-Q/A FORM 10-Q AMENDMENT 0001019687-15-004177 000-52403 151237153 34 990263 1
2015-11-17 10-Q/A FORM 10-Q AMENDMENT 0001019687-15-004175 000-52403 151237144 34 1159436 1
2015-11-17 10-Q/A FORM 10-Q AMENDMENT 0001019687-15-004173 000-52403 151237138 34 1070092 1
2015-10-23 10-K/A CANNABICS PHARMACEUTICALS INC. 0001019687-15-003780 000-52403 151172038 34 1863286 1
2015-10-20 CORRESP filename1.htm 0001019687-15-003759 50153
2015-10-14 CORRESP filename1.htm 0001019687-15-003713 21555
2015-10-13 8-K FORM 8-K 4.02 0001019687-15-003690 000-52403 151154678 34 14408
2015-10-08 8-K FORM 8-K 1.01,9.01 0001019687-15-003653 000-52403 151150085 34 70235
2015-09-15 UPLOAD filename1.pdf 0000000000-15-045720 255543
2015-08-19 CORRESP filename1.htm 0001019687-15-003213 635693
2015-07-28 CORRESP filename1.htm 0001019687-15-002887 27901
2015-07-15 10-Q QUARTERLY REPORT 0001019687-15-002769 000-52403 15989276 34 984400 1
2015-07-15 10-Q/A FORM 10-Q/A 0001019687-15-002767 000-52403 15989265 34 1148986 1
2015-07-10 CORRESP filename1.htm 0001019687-15-002671 24230
2015-06-22 UPLOAD filename1.pdf 0000000000-15-032799 254905
2015-05-28 CORRESP filename1.htm 0001019687-15-002175 82991
2015-05-28 8-K FORM 8-K 7.01 0001019687-15-002171 000-52403 15893538 34 12953
2015-05-15 CORRESP filename1.htm 0001019687-15-001967 24028
2015-05-05 UPLOAD filename1.pdf 0000000000-15-024700 256388
2015-04-21 CORRESP filename1.htm 0001019687-15-001576 79387
2015-04-20 10-Q CANNABICS PHARMACEUTICALS, INC. 0001019687-15-001536 000-52403 15780539 34 1293369 1
2015-04-14 NT 10-Q EXTENSION 0001019687-15-001426 000-52403 15768606 34 14692
2015-04-09 8-K CURRENT REPORT ON FORM 8-K 5.02,9.01 0001019687-15-001374 000-52403 15761835 34 45161
2015-04-07 CORRESP filename1.htm 0001019687-15-001325 34291
2015-03-23 UPLOAD filename1.pdf 0000000000-15-017141 276053
2015-02-17 8-K FORM 8-K 1.01,9.01 0001019687-15-000618 000-52403 15621248 34 14011
2015-02-03 8-K CURRENT REPORT ON FORM 8-K 1.01 0001019687-15-000413 000-52403 15569342 34 12640
2015-01-23 8-K CURRENT REPORT ON FORM 8-K 5.02,9.01 0001019687-15-000312 000-52403 15545552 34 24207
2015-01-20 10-Q FORM 10-Q 0001019687-15-000244 000-52403 15533985 34 1287385 1
2015-01-14 NT 10-Q NOTICE OF LATE FILING 0001019687-15-000190 000-52403 15527304 34 14985
2015-01-06 8-K FORM 8-K 1.01,9.01 0001019687-15-000073 000-52403 15508401 34 59404
2014-12-16 8-K CURRENT REPORT 8.01 0001019687-14-004720 000-52403 141287771 34 12609
2014-12-15 10-K FORM 10-K 0001019687-14-004710 000-52403 141285928 34 2083558 1
2014-12-01 NT 10-K EXTENSION 0001019687-14-004538 000-52403 141256828 34 14569
2014-11-05 8-K CURRENT REPORT ON FORM 8-K 1.01,9.01 0001019687-14-004055 000-52403 141195858 34 82249
2014-08-01 8-K FORM 8-K 7.01 0001019687-14-002922 000-52403 141007811 34 13532
2014-07-25 8-K CURRENT REPORT ON FORM 8-K 1.01,9.01 0001019687-14-002800 000-52403 14992206 34 63427
2014-07-24 4 FORM 4 0001019687-14-002802 4897
2014-07-15 10-Q/A AMENDMENT TO QUARTERLY REPORT 0001019687-14-002733 000-52403 14975334 34 1171722 1
2014-07-14 10-Q QUARTERLY REPORT 0001019687-14-002718 000-52403 14972799 34 1184039 1
2014-07-11 4 FORM 4 0001019687-14-002713 4936
2014-06-25 4 OWNERSHIP DOCUMENT 0001019687-14-002552 4776
2014-06-25 SC 13D SCHEDULE 13D 0001019687-14-002550 005-83146 14939698 34 21323
2014-06-25 SC 13D/A SCHEDULE 13-D 0001303681-14-000036 005-83146 14938418 34 23773
2014-06-24 4/A PRIMARY DOCUMENT 0001303681-14-000037 4919
2014-06-20 8-K FORM 8-K 5.03,9.01 0001019687-14-002488 000-52403 14931874 34 3275813
2014-05-01 SC 13D/A SCHEDULE 13D 0001303681-14-000032 005-83146 14801010 34 19048
2014-04-30 4 PRIMARY DOCUMENT 0001303681-14-000030 4227
2014-04-30 8-K CURRENT REPORT ON FORM 8-K 5.01,5.02,9.01 0001019687-14-001602 000-52403 14799180 34 81906
2014-04-08 8-K CURRENT REPORT 2.01 0001303681-14-000029 000-52403 14749786 34 11100
2014-04-01 10-Q QUARTERLY REPORT 0001303681-14-000026 000-52403 14731686 34 968615 1
2014-02-20 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2014-02-20 17:00:00 9999999995-14-000494 333-192759 14631559 33 1784
2014-02-19 CORRESP filename1.htm 0001303681-14-000020 6606
2014-02-11 S-1/A AMENDED REGISTRATION STATEMENT 0001303681-14-000017 333-192759 14590792 33 3154133 1
2014-01-31 S-1/A AMENDED REGISTRATION STATEMENT 0001303681-14-000012 333-192759 14564477 33 3130576 1
2014-01-29 UPLOAD filename1.pdf 0000000000-14-004606 58976
2014-01-24 S-1/A AMENDED REGISTRATION STATEMENT 0001303681-14-000008 333-192759 14545676 33 3163422 1
2014-01-15 10-Q/A QUARTERLY REPORT 0001303681-14-000005 000-52403 14528182 34 138320
2014-01-14 10-Q QUARTERLY REPORT 0001303681-14-000003 000-52403 14525237 34 923709 1
2014-01-03 UPLOAD filename1.pdf 0000000000-14-000390 159346
2013-12-11 S-1 REGISTRATION STATEMENT 0001303681-13-000117 333-192759 131269610 33 2956993 1
2013-12-09 10-K/A ANNUAL REPORT 0001303681-13-000114 000-52403 131265536 34 199159
2013-12-09 8-K CURRENT REPORT 5.03,9.01 0001303681-13-000112 000-52403 131265524 34 32696
2013-11-29 10-K/A ANNUAL REPORT 0001303681-13-000108 000-52403 131250472 34 198760
2013-11-29 10-K ANNUAL REPORT 0001303681-13-000105 000-52403 131250246 34 1409560 1
2013-11-25 SC 13D/A amcm_13d29oct13.htm 0001303681-13-000100 005-83146 131240630 34 19534
2013-11-25 8-K CURRENT REPORT 1.01,1.02,3.02 0001303681-13-000098 000-52403 131240482 34 15048
2013-11-04 4/A PRIMARY DOCUMENT 0001303681-13-000089 4546
2013-11-04 SC 13D/A amcm_13d29oct13.htm 0001303681-13-000088 005-83146 131188723 34 17876
2013-10-29 SC 13D amcm_13d29oct13.htm 0001303681-13-000084 005-83146 131176906 34 24008
2013-10-29 8-K CURRENT REPORT 1.01,9.01 0001303681-13-000082 000-52403 131176638 34 51086
2013-10-28 4 PRIMARY DOCUMENT 0001303681-13-000080 4304
2013-10-22 8-K CURRENT REPORT 7.01,9.01 0001303681-13-000077 000-52403 131162475 34 19600
2013-07-15 10-Q QUARTERLY REPORT 0001303681-13-000059 000-52403 13966739 34 1291544 1
2013-07-03 SC 13D/A SCHEDULE 13D 0001303681-13-000052 005-83146 13950331 34 27597
2013-07-02 4/A PRIMARY DOCUMENT 0001303681-13-000053 4767
2013-07-02 8-K CURRENT REPORT 1.01,3.02,9.01 0001303681-13-000049 000-52403 13949584 34 22091
2013-06-28 4 PRIMARY DOCUMENT 0001303681-13-000045 4568
2013-06-28 SC 13D SCHEDULE 13D 0001303681-13-000044 005-83146 13941774 34 92127
2013-06-28 8-K CURRENT REPORT 3.02 0001303681-13-000043 000-52403 13941761 34 10174
2013-04-15 10-Q QUARTERLY REPORT 0001303681-13-000024 000-52403 13759757 34 852763 1
2013-01-14 10-Q QUARTERLY REPORT 0001303681-13-000004 000-52403 13527972 34 837898 1
2012-11-30 10-K ANNUAL REPORT 0001303681-12-000140 000-52403 121233055 34 1310565 1
2012-11-29 NT 10-K NOTICE OF LATE FILING 0001303681-12-000138 000-52403 121230174 34 22287
2012-08-28 8-K CURRENT REPORT 5.02 0001303681-12-000110 000-52403 121060143 34 18636
2012-07-27 8-K CURRENT REPORT 5.02 0001303681-12-000084 000-52403 12988522 34 12784
2012-07-06 10-Q QUARTERLY REPORT 0001303681-12-000065 000-52403 12949226 34 805377 1
2012-04-17 8-K CURRENT REPORT 5.02 0001303681-12-000050 000-52403 12762270 34 11244
2012-04-13 10-Q QUARTERLY REPORT 0001303681-12-000048 000-52403 12758915 34 801449 1
2012-01-13 10-Q QUARTERLY REPORT 0001303681-12-000006 000-52403 12525949 34 775492 1
2011-11-29 10-K ANNUAL REPORT 0001303681-11-000207 000-52403 111231130 34 1022950 1
2011-11-17 8-K/A amcm_8k40108nov11.htm 4.01,9.01 0001303681-11-000203 000-52403 111212677 34 20616
2011-11-14 4 PRIMARY DOCUMENT 0001303681-11-000200 4934
2011-11-14 8-K CURRENT REPORT 1.01,1.02,2.01,5.01,9.01 0001303681-11-000199 000-52403 111202782 34 47191
2011-11-14 8-K CURRENT REPORT 4.01 0001303681-11-000197 000-52403 111200299 34 12024
2011-11-07 8-K CURRENT REPORT 1.02,5.02 0001303681-11-000185 000-52403 111182592 34 15453
2011-07-21 10-Q QUARTERLY REPORT 0001303681-11-000151 000-52403 11978470 34 380650
2011-07-14 NT 10-Q NOTIFICATION OF LATE FILING 0001303681-11-000145 000-52403 11968407 34 5190
2011-07-05 8-K CURRENT REPORT 5.02,7.01,9.01 0001303681-11-000130 000-52403 11948917 34 10138
2011-06-29 8-K CURRENT REPORT 4.01,9.01 0001303681-11-000118 000-52403 11939496 34 7084
2011-06-29 SC 13D SCHEDULE 13D 0001303681-11-000116 005-83146 11937084 34 12877
2011-06-28 3 PRIMARY DOCUMENT 0001303681-11-000113 3789
2011-06-20 8-K CURRENT REPORT 1.01,2.03,3.02,9.01 0001303681-11-000104 000-52403 11921692 34 10893
2011-06-07 8-K CURRENT REPORT 1.01,2.01,3.02,5.01,5.02,5.06,9.01 0001303681-11-000096 000-52403 11897003 34 356569
2011-05-13 8-K CURRENT REPORT 3.03,5.03 0001303681-11-000078 000-52403 11840070 34 49808
2011-05-10 8-K CURRENT REPORT 5.03,8.01,9.01 0001303681-11-000071 000-52403 11826906 34 48143
2011-04-22 8-K CURRENT REPORT 1.01,3.02,5.03,9.01 0001303681-11-000068 000-52403 11774634 34 129260
2011-04-14 10-Q QUARTERLY REPORT 0001303681-11-000063 000-52403 11759090 34 47797
2011-01-18 10-Q QUARTERLY REPORT 0001303681-11-000015 000-52403 11531554 34 47477
2011-01-14 NT 10-Q NOTIFICATION OF LATE FILING 0001303681-11-000007 000-52403 11529654 34 5377
2010-11-29 10-K ANNUAL REPORT 0001303681-10-000176 000-52403 101218311 34 195965
2010-09-30 8-K CURRENT REPORT 5.03 0001303681-10-000147 000-52403 101098889 34 58688
2010-08-11 DEF 14C PRELIMINARY INFORMATION STATEMENT 0001303681-10-000093 000-52403 101007068 34 40283
2010-07-30 PRE 14C PRELIMINARY INFORMATION STATEMENT 0001303681-10-000081 000-52403 10980740 34 40194
2010-07-13 10-Q QUARTERLY REPORT 0001303681-10-000063 000-52403 10950169 34 51493
2010-06-01 10-Q/A QUARTERLY REPORT 0001303681-10-000053 000-52403 10867661 34 50954
2010-05-28 10-Q/A QUARTERLY REPORT 0001303681-10-000050 000-52403 10867207 34 47263
2010-04-15 10-Q QUARTERLY REPORT 0001303681-10-000034 000-52403 10750489 34 48820
2010-01-14 10-Q QUARTERLY REPORT 0001303681-10-000009 000-52403 10527030 34 46978
2009-12-01 8-K CURRENT REPORT 2.01,5.06,7.01,9.01 0001303681-09-000083 000-52403 091213449 34 89925
2009-11-30 10-K ANNUAL REPORT 0001303681-09-000077 000-52403 091210556 34 94868
2009-07-10 10-Q QUARTERLY REPORT 0001303681-09-000044 000-52403 09937978 34 48876
2009-07-07 8-K/A CURRENT REPORT 1.01 0001303681-09-000042 000-52403 09932297 34 4725
2009-05-27 8-K CURRENT REPORT 1.01 0001303681-09-000037 000-52403 09853071 34 4574
2009-04-14 10-Q QUARTERLY REPORT 0001303681-09-000018 000-52403 09748435 34 45715
2009-01-13 10-Q QUARTERLY REPORT 0001303681-09-000006 000-52403 09523903 34 45288
2008-11-28 10KSB/A ANNUAL REPORT 0001303681-08-000091 000-52403 081219205 34 85993
2008-11-26 10KSB ANNUAL REPORT 0001303681-08-000089 000-52403 081217264 34 86163
2008-07-07 10QSB QUARTERLY REPORT ON FORM 10QSB 0001303681-08-000067 000-52403 08940893 34 44077
2008-04-14 10QSB QUARTERLY REPORT 0001303681-08-000049 000-52403 34 45049
2008-01-14 10QSB QUARTERLY REPORT ON FORM 10QSB 0001303681-08-000006 000-52403 08527398 34 43797
2007-11-21 10KSB/A ANNUAL REPORT ON FORM 10KSB 0001303681-07-000056 000-52403 071261107 34 114116
2007-11-21 10KSB ANNUAL REPORT ON FORM 10KSB 0001303681-07-000055 000-52403 071260934 34 114110
2007-09-26 4 PRIMARY DOCUMENT 0001303681-07-000047 4766
2007-09-26 4 PRIMARY DOCUMENT 0001303681-07-000046 4898
2007-09-26 SC 13D SCHEDULE 13D 0001303681-07-000045 005-83146 071136362 34 14208
2007-08-28 8-K CURRENT REPORT ON FORM 8-K 5.02 0001303681-07-000043 000-52403 071081743 34 4137
2007-07-09 10QSB QUATERLY REPORT ON FORM 10QSB 0001303681-07-000033 000-52403 07969276 34 46611
2007-04-12 10QSB QUARTERLY REPORT ON FORM 10QSB 0001303681-07-000021 000-52403 07762171 34 44065
2007-03-29 10QSB/A QUARTERLY REPORT ON FORM 10QSB 0001303681-07-000018 000-52403 07728470 34 43132
2007-03-29 10KSB/A ANNUAL REPORT ON FORM 10KSB 0001303681-07-000016 000-52403 07728370 34 475180
2007-01-16 8-A12G REGISTRATION OF SECURITIES ON FORM 8A12G 0001303681-07-000008 000-52403 07529671 34 4924
2007-01-12 10QSB QUARTERLY REPORT ON FORM 10QSB 0001303681-07-000004 333-130922 07529300 34 43116
2006-11-06 10KSB ANNUAL REPORT ON FORM 10KSB 0001303681-06-000100 333-130922 061189550 34 475160
2006-07-12 10QSB QUARTERLY REPORT ON FORM 10-QSB 0001303681-06-000059 333-130922 06956978 34 40077
2006-04-20 424B3 thrust_prospectus.txt 0001303681-06-000045 333-130922 06770344 33 185924
2006-04-13 3 PRIMARY DOCUMENT 0001179311-06-000002 3854
2006-04-12 3 PRIMARY DOCUMENT 0001179309-06-000001 3854
2006-04-12 CORRESP filename1.txt 0001303681-06-000043 3372
2006-04-10 SB-2/A AMENDED REGISTRATION STATEMENT ON FORM SB-2/A 0001303681-06-000037 333-130922 06749394 33 437409
2006-04-03 UPLOAD filename1.txt 0000000000-06-015604 6938
2006-03-14 SB-2/A doc1.txt 0001303681-06-000014 333-130922 06683485 33 222853
2006-02-03 UPLOAD filename1.txt 0000000000-06-006121 19101
2006-01-09 SB-2 doc1.txt 0001303681-06-000005 333-130922 06519662 33 322254

Latest XBRL company facts

One latest value per concept from companyfacts (292 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 1.61B 2026-06-17 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
dei EntityPublicFloat Entity Public Float USD 251,840 2025-08-31 2025 FY 10-K 2025-12-01 0001683168-25-008736
us-gaap AccountsAndOtherReceivablesNetCurrent Accounts and Other Receivables, Net, Current USD 94,960 2010-08-31 2011 FY 10-K 2011-11-29 0001303681-11-000207
us-gaap AccountsPayableAndAccruedLiabilities Accounts Payable and Accrued Liabilities (Deprecated 2009-01-31) USD 45,890 2011-05-31 2012 Q3 10-Q 2012-07-06 0001303681-12-000065
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 45,228 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap AccountsPayableRelatedParties Accounts Payable, Related Parties (Deprecated 2009-01-31) USD 17,544 2011-05-31 2012 Q3 10-Q 2012-07-06 0001303681-12-000065
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current USD 223,645 2022-11-30 2023 Q1 10-Q 2023-01-13 0001683168-23-000174
us-gaap AccountsPayableRelatedPartiesCurrentAndNoncurrent Accounts Payable, Related Parties USD 310,557 2022-11-30 2023 Q1 10-Q 2023-01-13 0001683168-23-000174
us-gaap AccountsReceivableRelatedPartiesCurrent Accounts Receivable, Related Parties, Current USD 127,768 2015-11-30 2016 Q1 10-Q 2016-01-22 0001019687-16-004908
us-gaap AccruedRentCurrent Accrued Rent, Current USD 4,000 2016-05-31 2016 Q3 10-Q 2016-07-13 0001019687-16-006908
us-gaap AccruedSalariesCurrentAndNoncurrent Accrued Salaries USD 189,286 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap AccumulatedOtherComprehensiveIncomeLossBeforeTax Accumulated Other Comprehensive Income (Loss), before Tax (Deprecated 2009-01-31) USD 56,401 2013-08-31 2013 FY 10-K 2013-11-29 0001303681-13-000105
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 0 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap AcquisitionCosts Acquisition Costs, Period Cost USD 864 2004-09-15 2014-05-31 2014 Q3 10-Q 2014-07-15 0001019687-14-002733
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 22.77M 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 139,720 2023-09-01 2024-08-31 2025 FY 10-K 2025-12-01 0001683168-25-008736
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 675,123 2020-09-01 2021-08-31 2022 FY 10-K 2022-11-30 0001683168-22-008095
us-gaap AdvanceRoyaltiesCurrent Advance Royalties, Current USD 0 2020-08-31 2020 FY 10-K 2020-11-04 0001683168-20-003686
us-gaap AdvanceRoyaltiesNoncurrent Advance Royalties, Noncurrent USD 0 2020-08-31 2020 FY 10-K 2020-11-04 0001683168-20-003686
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 0 2024-09-01 2025-08-31 2025 FY 10-K 2025-12-01 0001683168-25-008736
us-gaap AllowanceForLoanAndLeaseLossesLoansSold Allowance for Loan and Lease Losses, Loans Sold USD 94,960 2010-09-01 2011-08-31 2013 Q3 10-Q 2013-07-15 0001303681-13-000059
us-gaap AllowanceForLoanAndLeaseLossesWriteOffs Allowance for Loan and Lease Losses, Write-offs USD 94,960 2004-09-15 2014-05-31 2014 Q3 10-Q 2014-07-15 0001019687-14-002733
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 0 2016-09-01 2017-08-31 2017 FY 10-K 2017-12-08 0001683168-17-003260
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 0 2020-09-01 2021-08-31 2021 FY 10-K 2021-11-29 0001683168-21-006005
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 97,635 2004-09-15 2014-05-31 2014 Q3 10-Q 2014-07-15 0001019687-14-002733
us-gaap Assets Assets USD 12,795 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap AssetsCurrent Assets, Current USD 12,795 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap AvailableForSaleEquitySecuritiesGrossUnrealizedGain Available-for-sale Equity Securities, Gross Unrealized Gain USD 48,546 2019-09-01 2020-05-31 2020 Q3 10-Q 2020-07-14 0001683168-20-002257
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 981,157 2021-05-31 2021 Q3 10-Q 2021-07-14 0001683168-21-002970
us-gaap AvailableForSaleSecuritiesCurrent Available-for-sale Securities, Current USD 1.08M 2020-05-31 2020 Q3 10-Q 2020-07-14 0001683168-20-002257
us-gaap AvailableForSaleSecuritiesGrossRealizedGainLossNet Available-for-sale Securities, Gross Realized Gain (Loss) USD 195,968 2020-09-01 2021-05-31 2021 Q3 10-Q 2021-07-14 0001683168-21-002970
us-gaap AvailableForSaleSecuritiesNoncurrent Available-for-sale Securities, Noncurrent USD 3.03M 2020-05-31 2020 Q3 10-Q 2020-07-14 0001683168-20-002257
us-gaap BankAcceptancesExecuted Bank Acceptances Executed USD 5,000 2023-08-31 2023 FY 10-K 2023-11-30 0001683168-23-008557
us-gaap BusinessCombinationAcquisitionRelatedCosts Business Combination, Acquisition Related Costs USD -18,750 2011-09-01 2012-08-31 2013 FY 10-K 2013-11-29 0001303681-13-000105
us-gaap BusinessDevelopment Business Development USD 105,227 2004-09-15 2014-05-31 2014 Q3 10-Q 2014-07-15 0001019687-14-002733
us-gaap CarryingCostsPropertyAndExplorationRights Carrying Costs, Property and Exploration Rights USD 3,547 2004-09-15 2014-05-31 2014 Q3 10-Q 2014-07-15 0001019687-14-002733
us-gaap Cash Cash USD 1,076 2014-02-28 2014 Q2 10-Q 2014-04-01 0001303681-14-000026
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 9,487 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -593,810 2020-09-01 2020-11-30 2021 Q1 10-Q 2021-01-14 0001683168-21-000156
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 9,487 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -11,305 2024-09-01 2025-08-31 2025 FY 10-K 2025-12-01 0001683168-25-008736
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -5,624 2025-09-01 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 14 2013-05-31 2013 Q3 10-Q 2013-07-15 0001303681-13-000059
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2025-08-31 2025 FY 10-K 2025-12-01 0001683168-25-008736
us-gaap CashPeriodIncreaseDecrease Cash, Period Increase (Decrease) USD 25,229 2015-09-01 2016-05-31 2016 Q3 10-Q 2016-07-13 0001019687-16-006908
us-gaap CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations Cash Provided by (Used in) Operating Activities, Discontinued Operations USD 0 2015-09-01 2015-11-30 2016 Q1 10-Q 2016-01-22 0001019687-16-004908
us-gaap CommonStockConvertibleConversionPriceDecrease Common Stock, Convertible, Conversion Price, Decrease USD/shares 42 2020-12-01 2020-12-16 2022 FY 10-K 2022-11-30 0001683168-22-008095
us-gaap CommonStockConvertibleConversionPriceIncrease Common Stock, Convertible, Conversion Price, Increase USD/shares 42 2020-12-01 2020-12-16 2022 FY 10-K 2022-11-30 0001683168-22-008095
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 1.80B 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 1.48B 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 1.48B 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap CommonStockSharesSubscribedButUnissued Common Stock, Shares Subscribed but Unissued shares 0 2017-08-31 2017 FY 10-K 2017-12-08 0001683168-17-003260
us-gaap CommonStockSharesSubscriptions Common Stock, Value, Subscriptions USD 3.13M 2016-02-29 2016 Q2 10-Q 2016-04-18 0001019687-16-005913
us-gaap CommonStockShareSubscribedButUnissuedSubscriptionsReceivable Common Stock, Share Subscribed but Unissued, Subscriptions Receivable USD -100,000 2017-02-28 2017 Q2 10-Q 2017-04-14 0001683168-17-000931
us-gaap CommonStockShareSubscriptionsButUnissuedValue Common Stock, Share Subscriptions but Unissued, Value (Deprecated 2009-01-31) USD -165,000 2006-09-01 2007-08-31 2013 FY 10-K 2013-11-29 0001303681-13-000105
us-gaap CommonStockValue Common Stock, Value, Issued USD 147,576 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -311,982 2025-09-01 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 100,000 2013-09-01 2014-05-31 2014 Q3 10-Q 2014-07-15 0001019687-14-002733
us-gaap ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued shares 40.00M 2013-09-01 2014-05-31 2014 Q3 10-Q 2014-07-15 0001019687-14-002733
us-gaap ConvertibleDebt Convertible Debt USD 20,000 2015-11-01 2016 Q1 10-Q/A 2016-04-08 0001019687-16-005788
us-gaap ConvertibleDebtCurrent Convertible Debt, Current USD 1.30M 2024-08-31 2024 FY 10-K 2024-11-29 0001683168-24-008433
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 1.05M 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap CostOfRevenue Cost of Revenue USD 0 2025-09-01 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap CostsAndExpenses Costs and Expenses USD 546,308 2004-09-15 2014-02-28 2014 Q2 10-Q 2014-04-01 0001303681-14-000026
us-gaap CostsIncurredAcquisitionOfOilAndGasProperties Costs Incurred, Acquisition of Oil and Gas Properties USD -30,000 2004-09-15 2014-05-31 2014 Q3 10-Q 2014-07-15 0001019687-14-002733
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 148,561 2025-09-01 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 921.81M 2025-09-01 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap DebtInstrumentInterestRateDuringPeriod Debt Instrument, Interest Rate During Period pure 0.18 2020-12-01 2020-12-16 2022 FY 10-K 2022-11-30 0001683168-22-008095
us-gaap DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage pure 0.1 2021-02-22 2022 FY 10-K 2022-11-30 0001683168-22-008095
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 125,000 2021-04-23 2022 FY 10-K 2022-11-30 0001683168-22-008095
us-gaap DebtSecuritiesTradingRealizedGainLoss Debt Securities, Trading, Realized Gain (Loss) USD 195,968 2020-09-01 2021-08-31 2021 FY 10-K 2021-11-29 0001683168-21-006005
us-gaap DeferredCompensationEquity Deferred Compensation Equity USD 0 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 50,000 2016-05-31 2016 Q3 10-Q 2016-07-13 0001019687-16-006908
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 163,700 2013-08-31 2013 FY 10-K 2013-11-29 0001303681-13-000105
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2025-08-31 2025 FY 10-K 2025-12-01 0001683168-25-008736
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 3.54M 2025-08-31 2025 FY 10-K 2025-12-01 0001683168-25-008736
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 3.54M 2025-08-31 2025 FY 10-K 2025-12-01 0001683168-25-008736
us-gaap Depreciation Depreciation USD 0 2025-09-01 2025-11-30 2026 Q1 10-Q 2026-01-14 0001683168-26-000285
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 2,153 2004-09-15 2014-05-31 2014 Q3 10-Q 2014-07-15 0001019687-14-002733
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 0 2018-08-31 2017 FY 10-K 2018-11-29 0001683168-18-003584
us-gaap DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic and Diluted Share USD/shares 0 2015-09-01 2015-11-30 2016 Q1 10-Q 2016-01-22 0001019687-16-004908
us-gaap DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities Disposal Group, Including Discontinued Operation, Accrued Liabilities USD 0 2015-11-30 2016 Q1 10-Q 2016-01-22 0001019687-16-004908
us-gaap DueFromRelatedPartiesCurrent Due from Related Parties, Current USD 8,147 2021-02-28 2021 Q2 10-Q 2021-04-14 0001683168-21-001374
us-gaap DueToOfficersOrStockholdersCurrentAndNoncurrent Due to Officers or Stockholders USD 0 2014-05-31 2014 Q3 10-Q 2014-07-15 0001019687-14-002733
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 223,645 2022-05-31 2022 Q3 10-Q 2022-07-14 0001683168-22-004948
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 0 2025-09-01 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.01 2021-09-01 2021-11-30 2022 Q1 10-Q 2022-01-13 0001683168-22-000244
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 0 2025-09-01 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2024-09-01 2025-08-31 2025 FY 10-K 2025-12-01 0001683168-25-008736
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2024-09-01 2025-08-31 2025 FY 10-K 2025-12-01 0001683168-25-008736
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0.21 2024-09-01 2025-08-31 2025 FY 10-K 2025-12-01 0001683168-25-008736
us-gaap EffectOfExchangeRateOnCash Effect of Exchange Rate on Cash USD 0 2015-09-01 2016-05-31 2016 Q3 10-Q 2016-07-13 0001019687-16-006908
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD 0 2019-09-01 2020-02-29 2020 Q2 10-Q 2020-04-13 0001683168-20-001154
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 0 2025-09-01 2026-02-28 2026 Q2 10-Q 2026-04-14 0001683168-26-002899
us-gaap EquipmentExpense Equipment Expense USD -2,153 2004-09-15 2014-05-31 2014 Q3 10-Q 2014-07-15 0001019687-14-002733
us-gaap EquityIssuancePerShareAmount Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) USD 0.005 2013-09-01 2013-11-30 2014 Q1 10-Q 2014-01-14 0001303681-14-000003
us-gaap EquityMethodInvestments Equity Method Investments USD 7.33M 2019-02-28 2019 Q2 10-Q 2019-04-15 0001683168-19-001033
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2014-09-01 2015-08-31 2015 FY 10-K 2016-01-07 0001019687-16-004727
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 1 2014-09-01 2015-08-31 2015 FY 10-K 2016-01-07 0001019687-16-004727
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.007 2014-09-01 2015-08-31 2015 FY 10-K 2016-01-07 0001019687-16-004727
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 864 2014-05-31 2014 Q3 10-Q 2014-07-15 0001019687-14-002733
us-gaap ForeignCurrencyTransactionGainBeforeTax Foreign Currency Transaction Gain, before Tax USD 18,226 2018-09-01 2019-08-31 2019 FY 10-K 2019-11-29 0001683168-19-003852
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD 2,096 2024-09-01 2025-08-31 2025 FY 10-K 2025-12-01 0001683168-25-008736
us-gaap ForeignCurrencyTransactionGainLossRealized Foreign Currency Transaction Gain (Loss), Realized USD 1,386 2015-09-01 2016-05-31 2016 Q3 10-Q 2016-07-13 0001019687-16-006908
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 4.88M 2018-09-01 2019-02-28 2019 Q2 10-Q 2019-04-15 0001683168-19-001033
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 0 2015-09-01 2016-02-29 2016 Q2 10-Q 2016-04-18 0001019687-16-005913
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD 0 2021-09-01 2022-08-31 2022 FY 10-K 2022-11-30 0001683168-22-008095
us-gaap GainLossOnSaleOfBusiness Gain (Loss) on Disposition of Business USD -129,577 2015-09-01 2015-11-30 2016 Q1 10-Q 2016-01-22 0001019687-16-004908
us-gaap GainLossOnSaleOfInvestments Gain (Loss) on Sale of Investments USD 0 2015-09-01 2016-02-29 2016 Q2 10-Q 2016-04-18 0001019687-16-005913
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2024-09-01 2025-08-31 2025 FY 10-K 2025-12-01 0001683168-25-008736
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 31,787 2004-09-15 2014-05-31 2014 Q3 10-Q 2014-07-15 0001019687-14-002733
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 299,728 2025-09-01 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap GeneralInsuranceExpense General Insurance Expense USD 0 2024-09-01 2025-08-31 2025 FY 10-K 2025-12-01 0001683168-25-008736
us-gaap GoodwillAndIntangibleAssetImpairment Goodwill and Intangible Asset Impairment USD 0 2014-09-01 2015-05-31 2015 Q3 10-Q/A 2015-11-17 0001019687-15-004177
us-gaap GrossProfit Gross Profit USD 0 2025-09-01 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap ImpairmentOfOilAndGasProperties Impairment of Oil and Gas Properties USD 0 2014-09-01 2015-08-31 2015 FY 10-K 2016-01-07 0001019687-16-004727
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD -336,467 2014-09-01 2015-05-31 2015 Q3 10-Q/A 2015-11-17 0001019687-15-004177
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -3.04M 2017-09-01 2018-05-31 2018 Q3 10-Q 2018-07-16 0001683168-18-001952
us-gaap IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -541,387 2014-09-01 2015-08-31 2015 FY 10-K 2016-01-07 0001019687-16-004727
us-gaap IncomeLossFromContinuingOperationsPerBasicAndDilutedShare Income (Loss) from Continuing Operations, Per Basic and Diluted Share USD/shares 0.004 2015-09-01 2015-11-30 2016 Q1 10-Q 2016-01-22 0001019687-16-004908
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTax Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD 0 2015-09-01 2015-11-30 2016 Q1 10-Q/A 2016-04-08 0001019687-16-005788
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share USD/shares 0 2014-09-01 2015-08-31 2015 FY 10-K 2016-01-07 0001019687-16-004727
us-gaap IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax Income (Loss) from Individually Significant Component Disposed of or Held-for-sale, Excluding Discontinued Operations, before Income Tax USD 0 2015-09-01 2015-11-30 2016 Q1 10-Q 2016-01-22 0001019687-16-004908
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2016-09-01 2017-02-28 2017 Q2 10-Q 2017-04-14 0001683168-17-000931
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2017-09-01 2018-05-31 2018 Q3 10-Q 2018-07-16 0001683168-18-001952
us-gaap IncreaseDecreaseInAccountsAndOtherReceivables Increase (Decrease) in Accounts and Other Receivables USD -18 2025-09-01 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 187,832 2025-09-01 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap IncreaseDecreaseInAccountsPayableRelatedParties Increase (Decrease) in Accounts Payable, Related Parties USD -589 2016-09-01 2017-02-28 2017 Q2 10-Q 2017-04-14 0001683168-17-000931
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 1,773 2015-09-01 2016-05-31 2016 Q3 10-Q 2016-07-13 0001019687-16-006908
us-gaap IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets Increase (Decrease) in Accounts Receivable and Other Operating Assets USD 10,013 2015-09-01 2015-11-30 2016 Q1 10-Q/A 2016-04-08 0001019687-16-005788
us-gaap IncreaseDecreaseInAccruedInterestReceivableNet Increase (Decrease) in Accrued Interest Receivable, Net USD 0 2018-09-01 2019-05-31 2019 Q3 10-Q 2019-07-15 0001683168-19-002195
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 0 2016-09-01 2017-08-31 2017 FY 10-K 2017-12-08 0001683168-17-003260
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD 0 2018-09-01 2019-08-31 2019 FY 10-K 2019-11-29 0001683168-19-003852
us-gaap IncreaseDecreaseInDueFromRelatedParties Increase (Decrease) in Due from Related Parties USD 0 2015-09-01 2015-11-30 2016 Q1 10-Q/A 2016-04-08 0001019687-16-005788
us-gaap IncreaseDecreaseInDueToRelatedParties Increase (Decrease) in Due to Related Parties USD 0 2017-09-01 2018-02-28 2018 Q2 10-Q 2018-04-05 0001683168-18-000930
us-gaap IncreaseDecreaseInDueToRelatedPartiesCurrent Increase (Decrease) in Due to Related Parties, Current USD 0 2018-09-01 2019-08-31 2019 FY 10-K 2019-11-29 0001683168-19-003852
us-gaap IncreaseDecreaseInEquitySecuritiesFvNi Increase (Decrease) in Equity Securities, FV-NI USD -4.58M 2018-09-01 2019-02-28 2019 Q2 10-Q 2019-04-15 0001683168-19-001033
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD -1,492 2025-09-01 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap IncreaseDecreaseInNotesPayableRelatedPartiesCurrent Increase (Decrease) in Notes Payable, Related Parties, Current USD -23,740 2010-09-01 2011-08-31 2013 Q3 10-Q 2013-07-15 0001303681-13-000059
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD -196,768 2021-09-01 2021-11-30 2022 Q1 10-Q 2022-01-13 0001683168-22-000244
us-gaap IncreaseDecreaseInOtherReceivables Increase (Decrease) in Other Receivables USD 0 2021-09-01 2022-05-31 2022 Q3 10-Q 2022-07-14 0001683168-22-004948
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 10,418 2020-09-01 2021-08-31 2021 FY 10-K 2021-11-29 0001683168-21-006005
us-gaap IncreaseDecreaseInPrepaidExpensesOther Increase (Decrease) in Prepaid Expenses, Other USD 16 2024-09-01 2025-02-28 2025 Q2 10-Q 2025-04-14 0001683168-25-002511
us-gaap IncreaseDecreaseInUnprovedOilAndGasProperty Increase (Decrease) in Unproved Oil and Gas Property USD -97,635 2004-09-15 2014-05-31 2014 Q3 10-Q 2014-07-15 0001019687-14-002733
us-gaap IntangibleAssetsNetIncludingGoodwill Intangible Assets, Net (Including Goodwill) USD 0 2015-08-31 2016 FY 10-K 2016-12-13 0001683168-16-000925
us-gaap InterestAndDebtExpense Interest and Debt Expense USD 2,151 2004-09-15 2014-05-31 2014 Q3 10-Q 2014-07-15 0001019687-14-002733
us-gaap InterestAndFeeIncomeLoansAndLeases Interest and Fee Income, Loans and Leases USD -345 2017-09-01 2018-08-31 2017 FY 10-K 2018-11-29 0001683168-18-003584
us-gaap InterestExpense Interest Expense USD 852 2017-09-01 2018-08-31 2017 FY 10-K 2018-11-29 0001683168-18-003584
us-gaap InterestExpenseBorrowings Interest Expense, Borrowings USD 39,819 2024-09-01 2025-08-31 2025 FY 10-K 2025-12-01 0001683168-25-008736
us-gaap InterestExpenseDebt Interest Expense, Debt USD 13,675 2025-09-01 2026-02-28 2026 Q2 10-Q 2026-04-14 0001683168-26-002899
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD -39,813 2024-09-01 2025-08-31 2025 FY 10-K 2025-12-01 0001683168-25-008736
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 370 2024-09-01 2025-08-31 2025 FY 10-K 2025-12-01 0001683168-25-008736
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2016-09-01 2017-02-28 2017 Q2 10-Q 2017-04-14 0001683168-17-000931
us-gaap Investments Investments USD 0 2024-08-31 2024 FY 10-K 2024-11-29 0001683168-24-008433
us-gaap InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures USD 589,722 2018-08-31 2017 FY 10-K 2018-11-29 0001683168-18-003584
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 0 2022-09-01 2023-05-31 2023 Q3 10-Q 2023-07-14 0001683168-23-004890
us-gaap LaborAndRelatedExpense Labor and Related Expense USD 33,487 2025-09-01 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 14,938 2014-09-01 2015-08-31 2016 Q1 10-Q/A 2016-04-08 0001019687-16-005788
us-gaap LegalFees Legal Fees USD 149,108 2022-09-01 2023-08-31 2023 FY 10-K 2023-11-30 0001683168-23-008557
us-gaap Liabilities Liabilities USD 586,212 2017-05-31 2017 Q3 10-Q 2017-07-17 0001683168-17-001782
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 12,795 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap LiabilitiesCurrent Liabilities, Current USD 2.67M 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap MarketingExpense Marketing Expense USD 0 2023-09-01 2024-08-31 2024 FY 10-K 2024-11-29 0001683168-24-008433
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 120,000 2025-09-01 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 3.78M 2016-09-01 2017-05-31 2017 Q3 10-Q 2017-07-17 0001683168-17-001782
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 0 2025-09-01 2025-11-30 2026 Q1 10-Q 2026-01-14 0001683168-26-000285
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -91,080 2016-09-01 2017-05-31 2017 Q3 10-Q 2017-07-17 0001683168-17-001782
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -125,624 2025-09-01 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -520,100 2016-09-01 2017-05-31 2017 Q3 10-Q 2017-07-17 0001683168-17-001782
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -311,982 2025-09-01 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 Noncash or Part Noncash Acquisition, Intangible Assets Acquired USD -4.41M 2013-09-01 2014-08-31 2014 FY 10-K 2014-12-15 0001019687-14-004710
us-gaap NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1 Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed) USD 4.41M 2013-09-01 2014-08-31 2014 FY 10-K 2014-12-15 0001019687-14-004710
us-gaap NoninterestExpenseTransferAgentAndCustodianFees Noninterest Expense Transfer Agent and Custodian Fees USD 974 2015-09-01 2016-02-29 2016 Q2 10-Q 2016-04-18 0001019687-16-005913
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -7,685 2018-09-01 2018-11-30 2019 Q1 10-Q 2019-01-17 0001683168-19-000146
us-gaap NotesPayableCurrent Notes Payable, Current USD 14,351 2016-02-29 2016 Q2 10-Q 2016-04-18 0001019687-16-005913
us-gaap NumberOfOperatingSegments Number of Operating Segments Integer 1 2026-03-01 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap NumberOfReportableSegments Number of Reportable Segments Integer 1 2026-03-01 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap OfficersCompensation Salary and Wage, Officer, Excluding Cost of Good and Service Sold USD 32,184 2014-09-01 2014-11-30 2015 Q1 10-Q/A 2015-11-17 0001019687-15-004173
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 601,122 2004-09-15 2014-05-31 2014 Q3 10-Q 2014-07-15 0001019687-14-002733
us-gaap OperatingExpenses Operating Expenses USD 299,728 2025-09-01 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -299,728 2025-09-01 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 57,178 2015-02-28 2015 Q2 10-Q/A 2015-11-17 0001019687-15-004175
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 23,877 2014-11-30 2015 Q1 10-Q/A 2015-11-17 0001019687-15-004173
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 0 2015-02-28 2015 Q2 10-Q/A 2015-11-17 0001019687-15-004175
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 0 2015-02-28 2015 Q2 10-Q/A 2015-11-17 0001019687-15-004175
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 7,797 2015-02-28 2015 Q2 10-Q/A 2015-11-17 0001019687-15-004175
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 31,188 2015-02-28 2015 Q2 10-Q/A 2015-11-17 0001019687-15-004175
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 0 2015-02-28 2015 Q2 10-Q/A 2015-11-17 0001019687-15-004175
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 18,193 2015-02-28 2015 Q2 10-Q/A 2015-11-17 0001019687-15-004175
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 25.27M 2025-08-31 2025 FY 10-K 2025-12-01 0001683168-25-008736
us-gaap OtherAdditionalCapital Other Additional Capital USD 0 2024-08-31 2024 FY 10-K 2024-11-29 0001683168-24-008433
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax USD -5.58M 2019-09-01 2020-05-31 2020 Q3 10-Q 2020-07-14 0001683168-20-002257
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD 0 2025-09-01 2026-02-28 2026 Q2 10-Q 2026-04-14 0001683168-26-002899
us-gaap OtherComprehensiveIncomeLossBeforeTax Other Comprehensive Income (Loss), before Tax USD -605,740 2021-09-01 2022-05-31 2022 Q3 10-Q 2022-07-14 0001683168-22-004948
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 762 2014-09-01 2015-05-31 2015 Q3 10-Q/A 2015-11-17 0001019687-15-004177
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD 2.57M 2022-09-01 2023-08-31 2024 FY 10-K 2024-11-29 0001683168-24-008433
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD 2.24M 2022-09-01 2023-02-28 2024 Q2 10-Q 2024-04-16 0001683168-24-002440
us-gaap OtherGeneralExpense Other General Expense USD 40,445 2024-09-01 2025-08-31 2025 FY 10-K 2025-12-01 0001683168-25-008736
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 0 2015-02-28 2015 Q2 10-Q/A 2015-11-17 0001019687-15-004175
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 42,285 2024-09-01 2025-08-31 2025 FY 10-K 2025-12-01 0001683168-25-008736
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 0 2021-09-01 2022-05-31 2022 Q3 10-Q 2022-07-14 0001683168-22-004948
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -12,254 2025-09-01 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap OtherPaymentsToAcquireBusinesses Other Payments to Acquire Businesses USD 150,000 2013-09-01 2014-08-31 2015 Q2 10-Q/A 2015-11-17 0001019687-15-004175
us-gaap OtherTaxCarryforwardGrossAmount Other Tax Carryforward, Gross Amount (Deprecated 2013-01-31) USD 19,740 2013-08-31 2013 FY 10-K 2013-11-29 0001303681-13-000105
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 0 2019-09-01 2020-05-31 2020 Q3 10-Q 2020-07-14 0001683168-20-002257
us-gaap PaymentsForProceedsFromAvailableforsaleSecuritiesShortterm Payments for (Proceeds from) Available-for-sale Securities, Short-term USD -2.23M 2019-09-01 2020-05-31 2020 Q3 10-Q 2020-07-14 0001683168-20-002257
us-gaap PaymentsForProceedsFromInvestments Payments for (Proceeds from) Investments USD 0 2020-09-01 2021-02-28 2021 Q2 10-Q 2021-04-14 0001683168-21-001374
us-gaap PaymentsForRent Payments for Rent USD 1,390 2019-05-01 2019-11-30 2020 Q2 10-Q 2020-04-13 0001683168-20-001154
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2019-09-01 2020-08-31 2020 FY 10-K 2020-11-04 0001683168-20-003686
us-gaap PaymentsToAcquireAvailableForSaleSecurities Payments to Acquire Available-for-sale Securities USD 0 2019-09-01 2020-08-31 2020 FY 10-K 2020-11-04 0001683168-20-003686
us-gaap PaymentsToAcquireEquityMethodInvestments Payments to Acquire Equity Method Investments USD 1.92M 2018-09-01 2019-02-28 2019 Q2 10-Q 2019-04-15 0001683168-19-001033
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 1.92M 2018-09-01 2019-05-31 2019 Q3 10-Q 2019-07-15 0001683168-19-002195
us-gaap PaymentsToAcquireLand Payments to Acquire Land USD 0 2015-09-01 2016-02-29 2016 Q2 10-Q 2016-04-18 0001019687-16-005913
us-gaap PaymentsToAcquireMachineryAndEquipment Payments to Acquire Machinery and Equipment USD 0 2025-09-01 2025-11-30 2026 Q1 10-Q 2026-01-14 0001683168-26-000285
us-gaap PaymentsToAcquireOilAndGasProperty Payments to Acquire Oil and Gas Property USD 0 2014-09-01 2015-05-31 2015 Q3 10-Q/A 2015-11-17 0001019687-15-004177
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2015-09-01 2016-05-31 2016 Q3 10-Q 2016-07-13 0001019687-16-006908
us-gaap PaymentsToAcquireRoyaltyInterestsInMiningProperties Payments to Acquire Royalty Interests in Mining Properties USD 0 2014-09-01 2015-08-31 2015 FY 10-K 2016-01-07 0001019687-16-004727
us-gaap PaymentsToAcquireTradingSecuritiesHeldforinvestment Payments to Acquire Trading Securities Held-for-investment USD 3.11M 2018-09-01 2019-08-31 2019 FY 10-K 2019-11-29 0001683168-19-003852
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 3,308 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 80,772 2022-08-31 2022 FY 10-K 2022-11-30 0001683168-22-008095
us-gaap ProceedsFromCollaborators Proceeds from Collaborators USD 0 2014-09-01 2015-08-31 2015 FY 10-K 2016-01-07 0001019687-16-004727
us-gaap ProceedsFromContributedCapital Proceeds from Contributed Capital USD 20,000 2015-09-01 2015-11-30 2016 Q1 10-Q 2016-01-22 0001019687-16-004908
us-gaap ProceedsFromContributionsFromAffiliates Proceeds from Contributions from Affiliates USD -100,000 2013-09-01 2014-02-28 2014 Q2 10-Q 2014-04-01 0001303681-14-000026
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 0 2025-09-01 2025-11-30 2026 Q1 10-Q 2026-01-14 0001683168-26-000285
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2021-09-01 2022-05-31 2022 Q3 10-Q 2022-07-14 0001683168-22-004948
us-gaap ProceedsFromIssuanceOfSeniorLongTermDebt Proceeds from Issuance of Senior Long-term Debt USD 2.75M 2020-12-01 2020-12-16 2022 FY 10-K 2022-11-30 0001683168-22-008095
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 30,000 2024-09-01 2024-11-30 2025 Q1 10-Q 2025-01-13 0001683168-25-000267
us-gaap ProceedsFromLicenseFeesReceived Proceeds from License Fees Received USD 50,000 2016-03-01 2016-05-31 2016 Q3 10-Q 2016-07-13 0001019687-16-006908
us-gaap ProceedsFromLoans Proceeds from Loans USD 240,000 2022-03-15 2022-03-16 2022 Q3 10-Q 2022-07-14 0001683168-22-004948
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 1.38M 2021-04-01 2021-04-23 2022 FY 10-K 2022-11-30 0001683168-22-008095
us-gaap ProceedsFromOtherDebt Proceeds from Other Debt USD 0 2025-09-01 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 135,684 2014-09-01 2015-05-31 2015 Q3 10-Q/A 2015-11-17 0001019687-15-004177
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 645,968 2020-09-01 2021-05-31 2021 Q3 10-Q 2021-07-14 0001683168-21-002970
us-gaap ProceedsFromSaleOfAvailableForSaleSecurities Proceeds from Sale of Available-for-sale Securities USD 645,968 2020-09-01 2021-02-28 2021 Q2 10-Q 2021-04-14 0001683168-21-001374
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesDebt Proceeds from Sale of Debt Securities, Available-for-sale USD 0 2023-09-01 2024-05-31 2025 Q3 10-Q 2024-07-15 0001683168-24-004831
us-gaap ProceedsFromSaleOfEquitySecuritiesFvNi ProceedsFromSaleOfEquitySecuritiesFvNi USD 0 2023-09-01 2024-08-31 2024 FY 10-K 2024-11-29 0001683168-24-008433
us-gaap ProceedsFromSaleOfOtherPropertyPlantAndEquipment Proceeds from Sale of Other Property, Plant, and Equipment USD 114,673 2023-09-01 2024-05-31 2025 Q3 10-Q 2024-07-15 0001683168-24-004831
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2024-09-01 2025-08-31 2025 FY 10-K 2025-12-01 0001683168-25-008736
us-gaap ProceedsFromShortTermDebt Proceeds from Short-term Debt USD 120,000 2025-09-01 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap ProfessionalAndContractServicesExpense Professional and Contract Services Expense USD 64,851 2015-09-01 2016-02-29 2016 Q2 10-Q 2016-04-18 0001019687-16-005913
us-gaap ProfessionalFees Professional Fees USD 29,500 2015-09-01 2015-11-30 2016 Q1 10-Q 2016-01-22 0001019687-16-004908
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -2.51M 2020-09-01 2021-05-31 2021 Q3 10-Q 2021-07-14 0001683168-21-002970
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 0 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 102,228 2004-09-15 2014-05-31 2014 Q3 10-Q 2014-07-15 0001019687-14-002733
us-gaap RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments Realized Gain (Loss) on Marketable Securities, Cost Method Investments, and Other Investments USD 0 2019-09-01 2020-08-31 2020 FY 10-K 2020-11-04 0001683168-20-003686
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 0 2018-09-01 2019-08-31 2019 FY 10-K 2019-11-29 0001683168-19-003852
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 0 2018-09-01 2019-08-31 2019 FY 10-K 2019-11-29 0001683168-19-003852
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 589 2016-09-01 2017-05-31 2017 Q3 10-Q 2017-07-17 0001683168-17-001782
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 0 2025-09-01 2026-02-28 2026 Q2 10-Q 2026-04-14 0001683168-26-002899
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -25.58M 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap Revenues Revenues USD 0 2025-09-01 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap SalariesAndWages Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold USD 264,061 2021-09-01 2022-05-31 2022 Q3 10-Q 2022-07-14 0001683168-22-004948
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 114,674 2024-02-14 2024-02-15 2024 FY 10-K 2024-11-29 0001683168-24-008433
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 20.20M 2013-09-01 2014-02-28 2014 Q2 10-Q 2014-04-01 0001303681-14-000026
us-gaap SecurityDeposit Security Deposit USD 50,000 2021-05-31 2021 Q3 10-Q 2021-07-14 0001683168-21-002970
us-gaap SellingAndMarketingExpense Selling and Marketing Expense USD 3,820 2021-09-01 2021-11-30 2022 Q1 10-Q 2022-01-13 0001683168-22-000244
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 0 2025-09-01 2025-11-30 2026 Q1 10-Q 2026-01-14 0001683168-26-000285
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2021-09-01 2021-11-30 2022 Q1 10-Q 2022-01-13 0001683168-22-000244
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.11 2021-09-01 2021-11-30 2022 Q1 10-Q 2022-01-13 0001683168-22-000244
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.001 2021-09-01 2021-11-30 2022 Q1 10-Q 2022-01-13 0001683168-22-000244
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 4.50M 2021-09-01 2021-11-30 2022 Q1 10-Q 2022-01-13 0001683168-22-000244
us-gaap SharePrice Share Price USD/shares 0.14 2021-11-30 2022 Q1 10-Q 2022-01-13 0001683168-22-000244
us-gaap ShortTermBankLoansAndNotesPayable Short-term Bank Loans and Notes Payable USD 40,000 2025-11-30 2026 Q1 10-Q 2026-01-14 0001683168-26-000285
us-gaap ShortTermBorrowings Short-term Debt USD 120,000 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap ShortTermInvestments Short-term Investments USD 0 2020-08-31 2020 FY 10-K 2020-11-04 0001683168-20-003686
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -2.66M 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap StockIssued1 Stock Issued USD 0 2019-09-01 2020-08-31 2020 FY 10-K 2020-11-04 0001683168-20-003686
us-gaap StockIssuedDuringPeriodSharesAcquisitions Stock Issued During Period, Shares, Acquisitions shares 18.24M 2013-09-01 2014-08-31 2015 Q1 10-Q/A 2015-11-17 0001019687-15-004173
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 199.23M 2025-09-01 2025-11-30 2026 Q1 10-Q 2026-01-14 0001683168-26-000285
us-gaap StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans Stock Issued During Period, Shares, Employee Stock Purchase Plans shares 11.00M 2021-09-29 2021-10-03 2022 Q1 10-Q 2022-01-13 0001683168-22-000244
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 70,000 2014-09-01 2015-02-28 2015 Q2 10-Q/A 2015-11-17 0001019687-15-004175
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 62,500 2021-11-01 2021-11-30 2022 FY 10-K 2022-11-30 0001683168-22-008095
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 150,000 2013-09-01 2014-08-31 2015 FY 10-K 2016-01-07 0001019687-16-004727
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 148,561 2025-09-01 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 425,737 2021-09-01 2021-11-30 2023 Q1 10-Q 2023-01-13 0001683168-23-000174
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 1.05M 2021-11-01 2021-11-30 2022 FY 10-K 2022-11-30 0001683168-22-008095
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 4.41M 2016-09-01 2017-08-31 2017 FY 10-K 2017-12-08 0001683168-17-003260
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 30,000 2019-09-01 2020-02-29 2021 Q2 10-Q 2021-04-14 0001683168-21-001374
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD 0 2018-09-01 2019-08-31 2019 FY 10-K 2019-11-29 0001683168-19-003852
us-gaap UnrecognizedTaxBenefitsResultingInNetOperatingLossCarryforward Unrecognized Tax Benefits Resulting in Net Operating Loss Carryforward (Deprecated 2014-01-31) USD -19,740 2013-08-31 2013 FY 10-K 2013-11-29 0001303681-13-000105
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 70,495 2024-09-01 2025-08-31 2025 FY 10-K 2025-12-01 0001683168-25-008736
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 2.78M 2020-05-31 2020 Q3 10-Q 2020-07-14 0001683168-20-002257
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 995.58M 2025-09-01 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 144.73M 2021-09-01 2021-11-30 2022 Q1 10-Q 2022-01-13 0001683168-22-000244
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 995.58M 2025-09-01 2026-05-31 2026 Q3 10-Q 2026-06-24 0001683168-26-005078
us-gaap WeightedAverageNumberOfSharesOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31) shares 680,202 2011-05-31 2012 Q3 10-Q 2012-07-06 0001303681-12-000065

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →